Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.

AI/ML

Biotechnology

Health Care

Pharmaceutical

Xbiome

The Cambridge office specializes in advanced bioinformatics research and development for life sciences and healthcare innovations.

Cambridge

Yan Tan

Han Hu

正麒 陈

Shulin Wang

The Bioinformatics team at Xbiome analyzes complex biological data to support the development of microbial pharmaceuticals, focusing on identifying treatment targets and understanding microecological intestinal disorders. They employ computational tools and algorithms to interpret genetic, genomic, and microbial data, driving the research and development of effective therapies.

Bioinformatics

This department manages communication and relationships with investors to ensure effective engagement and transparency.

Investor Relations

This department focuses on the innovation, development, and improvement of probiotics and related products.

Research and Development

This department provides strategic direction and oversight for the organization, including high-level decision-making and vision implementation.

Executive Leadership

The Research and Science team at Xbiome conducts advanced studies to develop microbial pharmaceuticals for treating intestinal disorders. This team leverages cutting-edge research and comprehensive scientific methodologies to understand and manipulate microecological systems, ensuring the efficacy and safety of their treatments.

Xbiome

Org chart

Teams

Bioinformatics

Investor Relations

Research and Development

Executive Leadership

Research and Science

Offices

Xbiome

Org chart

Teams

Bioinformatics

Investor Relations

Research and Development

Executive Leadership

Research and Science

Offices

Related companies